Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on how myelodysplastic syndrome (MDS) patients who are ineligible for transplants can be managed.
How to Manage MDS Patients who are Ineligible for Transplant
